News

Find News

Filter articles

Showing 91 to 100 of 3629 results

A&O recruits five-strong Goodwin team, launches in Boston

24-02-2022

Allen & Overy has hired five partners from Goodwin Procter to boost its US life sciences litigation practice.

AstraZeneca sues Taro in blood-thinning drug patent dispute

24-02-2022

AstraZeneca has sued Taro Pharmaceuticals in two US federal courts alleging that Taro’s planned generic blood-thinning treatment infringes a patent for its Brilinta (ticagrelor) medication.

Otsuka says Teva’s REXULTI generic infringes patents

24-02-2022

Otsuka Pharmaceutical has sued Teva Pharmaceuticals, alleging that the company’s planned generic of Otsuka’s REXULTI antipsychotic (brexpiprazole) tablets infringe five of its patents.

Canada delivers landmark ruling in favour of big pharma

Canada22-02-2022

The Quebec Court of Appeal in Canada has ruled that the 2019 amendments to the Patented Medicines Regulations, governing the country’s Patented Medicine Prices Review Board (PMPRB) are partially invalid.

Janssen seeks to halt generic schizophrenia drug

India22-02-2022

Johnson & Johnson unit Janssen Pharmaceuticals has filed a suit against Intas Pharmaceuticals, seeking to block the India-based drugmaker from launching a generic version of schizophrenia drug Invega Sustenna (paliperidone palmitate).

Warren calls for government to seize Pfizer patents

22-02-2022

US Senator Elizabeth Warren has urged the Department of Health and Human Services (HHS) to seize control of patents covering Pfizer’s prostate cancer drug Xtandi (enzalutamide).

Pfizer sues Teva over arthritis treatment

US17-02-2022Alex Baldwin

Pfizer has sued Teva Pharmaceuticals, alleging that the Israeli pharma company is planning on releasing a generic of Pfizer’s Xeljanz XR arthritis treatment before the branded drug’s key patent expires.

Roche and AstraZeneca units settle blood drug suit

Japan, US17-02-2022

Roche’s Chugai and AstraZeneca’s Alexion Pharmaceuticals have brought their patent infringement dispute over a treatment for rare, fatal blood diseases to an end.

Judge partially revives California pay-for-delay ban

US17-02-2022

A Californian judge has partially revived the state’s pay-for-delay ban after attorney general Rob Bonta requested that a preliminary injunction against the ban be modified.

Afrigen creates COVID vaccine using Moderna data

South Africa15-02-2022Alex Baldwin

Afrigen Biologics has used the publicly available information relating to Moderna’s COVID-19 vaccine to manufacture its own version of the treatment, which could see testing by the end of this year.

Showing 91 to 100 of 3629 results

LSIPR